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Background: The prognosis of oral squamous cell carcinoma is very poor due to local recurrence and metastasis.
This study explores the molecular events involved in oral carcinoma with the goal of developing novel therapeutic
strategies. The mitotic spindle is a complex mechanical apparatus required for the accurate segregation of sister
chromosomes during mitosis. Spindle and kinetochore associated complex subunit 1 (SKA1) is a microtubule-
binding subcomplex of the outer kinetochore that is essential for proper chromosome segregation. In recent years,
much attention has been focused on determining how SKA proteins interact with each other, as well as their
biological role in cancer cells. However, the precise role of SKA1 in oral carcinoma remains unknown.
Methods: In order to investigate the role of SKA1 in oral cancer, we employed lentivirus-mediated shRNA to silence
SKA1 expression in the CAL-27 human oral adenosquamous carcinoma cell line.
Results: Depletion of SKA1 in CAL-27 cells significantly decreased cell proliferation, as determined by MTT and
colony formation assays. These results strongly demonstrate that reduced SKA1 protein levels may cause inhibition
of tumor formation. The shRNA-mediated depletion of SKA1 also led to G2/M phase cell cycle arrest and apoptosis.
Conclusion: This is the first report to show that SKA1 plays an important role in the progression of oral
adenosqamous carcinoma. Thus, silencing of SKA1 by RNAi might be a potential therapy for this disease.
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Worldwide, there are an estimated 405,000 new cases of
oral cancer diagnosed each year [1]. Despite advances in
the therapeutic management of squamous cell carcin-
oma over the last few decades, the prognosis is still very
poor due to local recurrence and metastasis [2-4]. This
disappointing outcome, even with existing therapies,
strongly suggests that novel targeted therapeutic agents
are needed to improve the treatment of patients diagnosed
with oral cancer. The successful use of small interfering
RNA (RNAi) to downregulate gene expression in several
model systems has led to many attempts to explore this* Correspondence: ywu@umcutrecht.nl; lshw@sdu.edu.cn
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reproduction in any medium, provided the ormethodology in cancer therapeutic settings [5]. RNAi is a
post-transcriptional mechanism of gene silencing through
chromatin remodeling, inhibition of protein translation,
or direct mRNA degradation, which is ubiquitous in
eukaryotic cells [6]. Along these lines, several recent studies
have documented the successful downregulation of gene
expression, resulting in increased apoptosis and decreased
proliferation in many cancer cell lines [4,7]. Long-lasting
RNAi-based gene silencing can be achieved using
lentivirus-based expression systems, which drive the pro-
duction of short hairpin RNAs (shRNAs) [8]. Lentiviral vec-
tors have become a promising tool for the establishment of
transgenic animals and manipulation of the mammalian
genome [9].
Mitotic chromosome segregation requires kinetochores
to generate physical connections between chromosomes
and spindle microtubule polymers [10]. Notably, spindleLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 2 Western blot analysis of SKA1 protein expression
levels in Lv-shSKA1-infected, LV-shCon-infected and uninfected
CAL-27 cells (Con). *p < 0.01. Data are representative of three
independent experiments.
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key properties, and play an important role in coupling
chromosome movement to microtubule depolymerization
[11,12]. Spindle and kinetochore associated complex sub-
unit 1 (SKA1) is a microtubule-binding subcomplex of the
outer kinetochore that is essential for proper chromosome
segregation [13,14]. Depletion of SKA1 proteins results in
sparse microtubule arrays that often exhibited twisted or
bent spindles. The chromosomes appear to interact with
the spindle microtubule, but fail to organize into metaphase
plates [15,16]. Much attention has been focused in recent
years on how SKA proteins interact with each other, and
their biological role in cancer cells. However, until now, the
precise role of SKA1 in oral carcinoma has remained un-
clear. Therefore, the goal of this study was to determine if
SKA1 plays a significant role in oral adenosquamous cell
carcinoma by using lentivirus-mediated shRNA for the
functional gene knockdown of SKA1 expression in CAL-27
cells.Results and discussion
Method validation
We used recombinant lentivirus harboring shRNA for
SKA1 to infect CAL-27 cells. The successful infection
and efficiency were confirmed by evaluating GFP expres-
sion levels. After infection, approximately 90% of cells
infected with Lv-shSKA1 expressed GFP (Figure 1).
These results suggest that the lentivirus infections are
successful and highly efficient. The effect of Lv-shSKA1
on SKA1 expression in CAL-27 cells was observed by
western blot analysis (Figure 2).
Western blot analysis showed that SKA1 protein was
not expressed in Lv-shSKA1 -infected cells. In contrast,
equal protein expression was observed in uninfected
cells and Lv-shCon-infected (negative control) cells.Figure 1 Infection of cells with lentiviral shRNA targeting SKA1
in CAL-27 cells. GFP expression in uninfected (Con), Lv-shSKA1-
infected, and Lv-shCon-infected CAL-27 cells indicates lentivirus
infection efficiency in CAL-27 cells. Transduction efficiency was
estimated 6 days after infection at MOI of 10. Light micrograph (left);
Fluorescent micrograph (right) (200×).Therefore, Lv-shSKA1 specifically and strongly abolished
SKA1 expression in CAL-27 cells.SKA1 affects CAL-27 cell proliferation
To elucidate the functional role of SKA1 in oral
adenosquamous carcinoma cells, we examined the effect
of SKA1 knockdown on the proliferation and colony
formation of CAL-27 cells. Cell proliferation was evalu-
ated by the MTT assay, and the results showed that
downregulation of SKA1 expression in CAL-27 cells
significantly decreased cell viability. Five days post-
infection, the viability of Lv-shSKA1-infected CAL-27
cells decreased compared to Lv-shCon-infected cells
(p < 0.01; Figure 3). Cell viability was the same in Lv-
shCon-infected and uninfected CAL-27 cells.Downregulation of SKA1 in CAL-27 cells significantly
reduces colony formation
To determine the role of SKA1 in human oral
adenosquamous tumorigenesis in vitro, we analyzed
CAL-27 tumor cell colony formation in a soft agar assay.
Downregulation of SKA1 in CAL-27 cells caused a sub-
stantial reduction in colony formation (Figures 4 and 5)
compared with uninfected and Lv-shCon-infected cells
(p < 0.01).
Results from the colony formation assay strongly indi-
cate that reduced SKA1 protein levels might result in
significant inhibition of tumor formation in human oral
adenosquamous cancer cells. Furthermore, the data
showed that SKA1 was critical for the proliferation and
tumorigenicity of human oral adenosquamous cancer
cells in vitro.
Figure 3 SKA1 affects the proliferation of CAL-27 cells. CAL-27
cells were seeded into 96-well plates at a density of 2.5 × 103 cells/
well in triplicate, and proliferation rates were measured by the MTT
assay. Data are representative of three independent experiments.
*p < 0.01.
Figure 4 SKA1 affects the colony formation of CAL-27 cells.
After 13 days, cells were stained with Giemsa to assess colony
formation rates. Quantification of colony formation rates in
uninfected, Lv-shSKA1-infected, and Lv-shCon-infected CAL-27 cells
are shown as histograms. Data are representative of three
independent experiments. Error bars represent standard deviation
(SD), *p < 0.01.
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Flow cytometry was used to determine the effect of Lv-
shSKA1 infection on the cell cycle of CAL-27 cells. As
shown in Table 1, down-regulation of SKA1 led to an ar-
rest in G 1/G 0 and G 2/M phase, the percentage of cells
in S phase reduced and sub-G 1 appeared. This cell cycle
analysis result suggesting the sequential events of cell
cycle arrest by SKA1 silencing in CAL-27 cells is
followed by apoptosis process. However, there were no
significant differences in cell cycle distribution between
in noninfected (Con) group and Lv-shCon group.
Discussion
Upon entry into mitosis, the microtubule network is
rearranged to form the mitotic spindle, which results in
segregation of sister chromatids [17-19]. Central to this
process is the proper attachment of spindle microtubules
to kinetochores, proteinaceous structures assembled on
centromeric chromatin [20]. Three subunits of the SKA1
complex (SKA1, SKA2, and SKA3/RAMA) are direct
components of the kinetochore-microtubule interface
[18]. SKA2 protein requires SKA1, a protein-binding
partner, for stability, and SKA2 is required for the cor-
rect assembly of SKA1 on the kinetochore [20]. It is well
established that depletion of the SKA complex leads to
apoptosis in many mammalian cell lines. Here, we evalu-
ated the effect of SKA1 depletion in CAL-27 cells. Ourresults showed that knockdown of SKA1 expression led
to reduced cell viability and increased apoptosis, as
anticipated.
To date, there are very few reports on the role of SKA
proteins in cancer formation and metastasis [21,22].
Clonogenic side population cells in some cancers, in-
cluding multiple human myeloma and primary tumors,
exhibit tumor-initiating characteristics. Gene expression
analysis showed that clonogenic side population cells in
cancers express genes involved in the cell cycle and mi-
tosis (e.g., SKA1, CCNB1, CDC25C, CDC2, BIRC5,
CENPE, AURKB, KIFs, TOP2A, ASPM) more strongly
than non-side population cells [23]. In accordance with
these reports, we found that SKA1 appears to be in-
volved in oral carcinoma by regulating spindle check-
point silencing and maintaining chromosome cohesion
in mitosis. To the best of our knowledge, this study is
the first to report that SKA1 expression is important in
oral adenosquamous cancer cell proliferation. These
findings will significantly enhance the current under-
standing of the role of the SKA complex in cancer cell
proliferation. It is worth noting that the present data are
only applicable to oral adenosquamous carcinomas.
Thus, studies in other cell lines could be of interest.
Moreover, future studies are needed to determine the
precise mechanism underlying SKA1 regulation of oral
adenosquamous cancer cell proliferation.
Figure 5 SKA1 affects the colony formation of CAL-27 cells.
Colonies stained with Giemsa were observed by light
microscopy (200×).
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This is the first report to show that SKA1 is important
in the proliferation of oral adenosquamous cells. Thus,




CAL-27 and HEK 293 T cells were maintained
in Dulbecco’s Modified Eagle’s Medium (DMEM)
containing 10% Fetal Bovine Serum (FBS), and 4 mM
L-glutamine, adjusted to contain 3.7 g/l sodium bicar-
bonate and 4.5 g/l glucose (Hyclone, Logan, UT). Cell
cultures were maintained as a monolayer in 75 cm2
tissue-culture treated flasks (Bedford, MA) at 37°C in a
humidified atmosphere of 5% CO2.
Lentivirus production and infection of CAL-27 cells
The cDNA sequence of SKA1 was obtained from
GenBank (accession number: NM_001039535). ShRNA
for SKA1 (5′-CCG-GCC-TGA-CAC-AAA-GCT-CCT-Table 1 SKA1 depletion affects the cell cycle of CAL-27
cells
Phase G0/G1 S G2/M Sub-G1
Con 59.03 ± 1.59 29.53 ± 2.66 11.40 ± 1.04 0.45 ± 0.06
Lv-shCon 56.33 ± 0.38 31.60 ± 0.78 12.07 ± 0.75 0.43 ± 0.06
Lv-shSKA1 61.73 ± 1.53** 19.27 ± 1.52 19.03 ± 0.49* 1.00 ± 0.06*
The flow cytometric analysis of cell cycle of uninfected CAL-27 cells (Con),
Lv-shSKA1, and Lv-shCon. The percentages of the cells in each phase of the
cycle are presented as the mean ± SD of three independent experiments.
*represents p < 0.05 between Lv-shSKA1group and Lv-shCon group.
**represents p < 0.01 between Lv-shSKA1group and Lv-shCon group. There
were no significant differences in cell cycle distribution between noninfected
(Con) group and Lv-shCon group (p > 0.05).AAA-TCT-CGA-GAT-TTA-GGA-GCT-TTG-TGT-CAG-
GTT-3′) was inserted into the lentivirus expression plas-
mid pFH-L (Shanghai Hollybio, China). Non-silencing
shRNA (5′-TTC-TCC-GAA-CGT-GTC-ACG-T-3′) was
used as a control. In order to generate SKA1-shRNA and
control lentivirus, lentiviral shRNA plasmids targeting
SKA1 or a control were transfected into HEK293T cells
using Lipofectamine 2000 (Invitrogen, Carlsbad, CA) to-
gether with the gag/pol packaging vector (pCMVΔR8.92,
Shanghai Hollybio, China) and the pVSVG-1 encoding
plasmid (Shanghai Hollybio) according to the manufac-
turer’s instructions. For lentivirus infection, CAL-27 cells
were grown at a density of 5 × 104 cells/well and infected
with SKA1-shRNA lentivirus or control lentivirus at a
MOI of 10.
Determine the infection efficiency of SKA1-shRNA
lentivirus
To determine the infection efficiency of SKA1-shRNA
lentivirus, CAL-27 cells expressing GFP protein were
observed by fluorescence microscopy (CKX41, Olympus,
Tokyo-Japan).
For western blot analysis, CAL-27 cells were grown
for 6 days. The cells were washed twice with ice-cold
PBS, scraped, centrifuged, and lysed in RIPA buffer with
PMSF (Beyotime Biotechnology, Jiangsu, China). Cell ex-
tracts were prepared on ice by ultrasonic disruption.
After centrifugation at 12,000 × g for 15 min at 4°C, the
supernatants were collected, and the protein concentra-
tions were determined using the BCA Protein Assay Kit.
Cell lysates were dissolved in 2x SDS sample buffer
(100 mM Tris–HCl pH 6.8, 10 mM EDTA, 4% SDS, 10%
glycine). Equal amounts of protein were resolved on 10%
SDS-PAGE gels and electrophoretically transferred onto
polyvinylidene fluoride membranes. Membranes were
blocked in 5% skim milk and hybridized with primary
antibodies (1:1000 dilution; SBA3500101, Sigma-Aldrich,
St. Louis, MO, USA). After incubation with horseradish-
peroxidase-conjugated secondary antibody (1:5000 dilu-
tion; sc-2004, Santa Cruz Biotechnology, Santa Cruz,
CA, USA) at room temperature, immunoreactive
proteins were detected using a Chemiluminescent ECL
Assay Kit (Amersham Pharmacia Biotech, UK), according
to the manufacturer’s instructions. GAPDH protein levels
were used as a control to verify equal protein loading. Band
intensities were analyzed with Quantity One analysis soft-
ware (Bio-Rad, Hercules, CA, USA).
MTT cell viability assay
In brief, both uninfected and infected CAL-27 cells
(2.5 × 103 cells/well) were seeded in 96-well plates. After
1, 2, 3, 4, or 5 days of infection, 100 μl MTT (5 mg/ml)
was added, followed by incubation for another 4 h at
37°C. The reaction was stopped by replacing the MTT-
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SDS, 5% isopropanol, 0.01 mol/l HCl), and the formazan
salts were dissolved by gentle shaking for about 10 min
at room temperature. For colorimetric analysis, the
absorbance at 595 nm was recorded using a microplate
reader (Bio-Rad). The optical of sample bands were
analyzed with Quantity One analysis software (Bio-Rad,
USA). Each assay was repeated at least three times.
Relative cell viability was compared to the untreated
(blank) group.Colony formation assay
Agar medium (0.8%) was prepared in 6-well plates.
Uninfected and infected CAL-27 cells were trypsinized,
centrifuged, resuspended in 0.4% agar medium (equal
volumes of 0.8% agar and culture medium), and plated
onto the top agar at 200 cells/well. Cell culture medium
was changed regularly. After 13 days of culture, adherent
cells were washed twice with PBS, and fixed in 4% para-
formaldehyde for 30 min at room temperature. Colonies
were stained with Giemsa solution for 72 h, washed with
water, and air-dried. The colonies were counted under a
fluorescence microscope.Cell cycle analysis
Uninfected and infected CAL-27 cells were seeded in
6-well culture plates at a density of 5 × 104 cells/well,
and incubated in complete medium to 70% confluence.
The cells were harvested, washed twice with ice-cold
PBS, and fixed in 75% cold ethanol at 4°C overnight.
Propidium iodide (PI) staining of nuclei was used to
monitor the cell cycle phases. The fluorescence of
DNA-bound PI in cells was measured with a Cell Lab
Quanta Beckman Coulter (Beckman Coulter, Miami,
FL, USA), and data were analyzed using Multi-Cycle AV
software (Phoenix Flow Systems, San Diego, CA, USA).Statistical analysis
PASW Statistics 18, Prism version 4.00 for Windows,
and InStat 3.0 software were used for statistical data
analyses. Numerical data were analyzed by one-way
ANOVA. Data are represented as mean and standard
error. Turkey’s test was used for multiple comparisons.
P values less than 0.05 were considered statistically
significant.
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